HUGHES, ADAM D.,FLEURY, MELISSA,RAPTA, MIROSLAV,THALLADI, VENKAT R.,FASS, GENE TIMOTHY,SIMEONE, MICHAEL,BALDWIN, R. MICHAEL,BOURDET, DAVID L.
申请号:
CA3015505
公开号:
CA3015505A1
申请日:
2017.03.07
申请国别(地区):
CA
年份:
2017
代理人:
摘要:
In one aspect, the invention relates to a crystalline form of the structure: or a pharmaceutically acceptable salt thereof, having neprilysin inhibition activity. In another aspect, the invention relates to pharmaceutical compositions comprising this crystalline form; methods of using this crystalline form and its soluble form (I); and processes for preparing soluble (I) and crystalline (I') forms.